Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
暂无分享,去创建一个
[1] I. Adcock,et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.
[2] P. Howe,et al. Disabled-2 (Dab2) Is Required for Transforming Growth Factor β-induced Epithelial to Mesenchymal Transition (EMT)* , 2005, Journal of Biological Chemistry.
[3] E. Hammond,et al. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad , 2005, Molecular Cancer Therapeutics.
[4] G. Dressler,et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease , 2005, Nature Medicine.
[5] H. Duan,et al. Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas , 2005, Molecular and Cellular Biology.
[6] F. Saatcioglu,et al. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells , 2005, The Prostate.
[7] Clara Nervi,et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. , 2005, Cancer research.
[8] Junwei Yang,et al. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. , 2004, Journal of the American Society of Nephrology : JASN.
[9] Y. Yoo,et al. Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion. , 2004, International journal of oncology.
[10] K. Miyazono,et al. A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation , 2004, Cell Death and Differentiation.
[11] L. Poellinger,et al. Induction of ID2 Expression by Hypoxia-inducible Factor-1 , 2004, Journal of Biological Chemistry.
[12] A. Nakao,et al. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. , 2004, Kidney international.
[13] Youhua Liu. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. , 2004, American journal of physiology. Renal physiology.
[14] Youhua Liu,et al. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. , 2004, Journal of the American Society of Nephrology : JASN.
[15] Raimund Hirschberg,et al. Bone Morphogenetic Protein-7 Signals Opposing Transforming Growth Factor β in Mesangial Cells* , 2004, Journal of Biological Chemistry.
[16] C. Heldin,et al. Id2 and Id3 Define the Potency of Cell Proliferation and Differentiation Responses to Transforming Growth Factor β and Bone Morphogenetic Protein , 2004, Molecular and Cellular Biology.
[17] Hanqiao Liu,et al. Phenylbutyrate decreases type I collagen production in human lung fibroblasts , 2004, Journal of cellular biochemistry.
[18] Tetsuhiro Tanaka,et al. Transdifferentiation of cultured tubular cells induced by hypoxia. , 2004, Kidney international.
[19] R. Kalluri,et al. The role of epithelial-to-mesenchymal transition in renal fibrosis , 2004, Journal of Molecular Medicine.
[20] Junwei Yang,et al. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling. , 2003, Journal of the American Society of Nephrology : JASN.
[21] A. Roberts,et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.
[22] S. Klahr,et al. Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. , 2003, Kidney international. Supplement.
[23] Junwei Yang,et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis , 2003 .
[24] R. Kalluri,et al. BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.
[25] R. Maestro,et al. Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)* , 2003, Journal of Biological Chemistry.
[26] Junwei Yang,et al. Transforming Growth Factor-β1 Potentiates Renal Tubular Epithelial Cell Death by a Mechanism Independent of Smad Signaling* , 2003, The Journal of Biological Chemistry.
[27] S. Klahr. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. , 2003, Journal of nephrology.
[28] G. Gilkeson,et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. , 2003, The Journal of clinical investigation.
[29] J. Fujimoto,et al. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. , 2002, Kidney international.
[30] D. Schuppan,et al. Trichostatin A, a Histone Deacetylase Inhibitor, Suppresses Collagen Synthesis and Prevents TGF-β1-Induced Fibrogenesis in Skin Fibroblasts , 2002 .
[31] D. Warburton,et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[32] J. Downward,et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.
[33] H. Moses,et al. Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.
[34] D. Schuppan,et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture , 1999, Hepatology.
[35] R. Kalluri,et al. Early role of Fsp1 in epithelial-mesenchymal transformation. , 1997, American journal of physiology. Renal physiology.
[36] Lucia Altucci,et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.
[37] R. Spanagel,et al. ERRATUM: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.
[38] Youhua Liu. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.
[39] Junwei Yang,et al. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. , 2002, Journal of the American Society of Nephrology : JASN.